AGNC Investment Corp.
AGNCNReal EstateNASDAQREIT - Mortgage
Scan Results
Daily timeframeAGNC Investment Corp. provides private capital to housing market in the United States. It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency.
Market Cap
—
Beta
1.34
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-1.86
EPS (Fwd)
—
ROE
0.9%
ROA
0.1%
Cash
$25.14B
Total Debt
$97.37B
Free CF
—
52W Change
-1.8%
Annual Financials
Cash vs Debt
Where AGNCN stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, AGNCN finished 1.37% above its 150-day moving average ($24.80) and 2.32% above its 200-day moving average ($24.57). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is AGNCN overbought or oversold?
At the October 20, 2026 close, AGNCN's RSI(14) was 52.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $25.14B in cash, though total debt stands at $97.37B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. ROE of 0.9% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $837.0M (2021) to $1.80B (2025), reflecting a 115% increase over the period.
As with any equity investment, AGNCN carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AGNCN.